LIMERICK, Pa., Apr 25, 2011 (BUSINESS WIRE) --
Teleflex Incorporated (NYSE: TFX), a leading global provider of
medical devices for critical care and surgery, has announced a new
three-year agreement with Amerinet, Inc., a national healthcare group
purchasing organization. Amerinet selected Arrow Peripherally Inserted
Central Catheters (PICCs) as part of a multi source agreement. The new
agreement begins May 1, 2011 and extends through April 30, 2014.
The Arrow PICC product line includes the recently introduced Arrow
EVOLUTION(TM) PICC with Chlorag+ard(TM) antimicrobial technology, the first
Chlorhexidine-treated peripherally inserted central catheter with both
intraluminal and extraluminal protection. Chlorag+ard technology
provides broad spectrum antimicrobial protection against bacterial and
fungal colonization.
The broad range of Arrow vascular access products includes central
venous access catheters, peripherally inserted central catheters, multi
access catheters and acute hemodialysis catheters many of which are now
available in ErgoPack Maximal Barrier Precautions Trays, a system
designed to support compliance with best practice and guidelines for
catheter insertion.
Teleflex also recently expanded its vascular access product offerings
with the acquisition of the VasoNova VPS, vascular positioning system, a
central venous catheter tip navigation system.
About Amerinet
As a leading national healthcare group purchasing organization, Amerinet
collaborates with acute and alternate care providers to create and
deliver unique solutions through performance improvement resources,
guidance and ongoing support. With better product standardization and
utilization, new financial tools beyond contracting and alliances that
help lower costs, raise revenue and champion quality, Amerinet enriches
healthcare delivery for its members and the communities they serve. To
learn more about how Amerinet can help you successfully navigate the
future of healthcare reform, visit www.amerinet-gpo.com.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a
range of procedures in critical care and surgery. Our mission is to
provide solutions that enable healthcare providers to improve outcomes
and enhance patient and provider safety. Headquartered in Limerick, PA,
Teleflex employs approximately 12,000 people worldwide and serves
healthcare providers in more than 130 countries. The company also has
niche businesses which produce specialty engineered products for the
aerospace market. For additional information about Teleflex please refer
to www.teleflex.com.
Forward-Looking Statements
Any statements contained in this press release that do not describe
historical facts may constitute forward-looking statements. Any
forward-looking statements contained herein are based on our
management's current beliefs and expectations, but are subject to a
number of risks, uncertainties and changes in circumstances, which may
cause actual results or company actions to differ materially from what
is expressed or implied by these statements. These risks and
uncertainties are identified and described in more detail in our filings
with the Securities and Exchange Commission, including our Annual Report
on Form 10-K.
SOURCE: Teleflex Incorporated
Teleflex Incorporated
Jake Elguicze
Vice President Investor Relations
610-948-2836